Hong Kong Stock Announcement Highlights | Biocytogen-B and Sihuan Pharmaceutical Form Strategic Partnership to Accelerate Innovative Drug Development in Weight Loss and Other Areas

Stock News
04/02

Major Developments: Biocytogen-B (02315) and Sihuan Pharmaceutical (00460) have entered into a strategic collaboration to accelerate the research and development of innovative drugs in multiple areas, including weight loss. Far East Consortium (00035) plans to sell a 49.9% stake in the Melbourne Ritz-Carlton Hotel. Datang Environment (01272) intends to acquire scrapped wind power equipment for approximately 24.5741 million yuan. Remegen (09995): The National Medical Products Administration has approved the clinical trial application for the bispecific antibody-drug conjugate (bispecific ADC) RC288 for injection. Easylife Holdings (00223): Initiated an AI digital supply chain strategic partnership with Yaao Supply Chain.

Operating Performance:恒盛地产 (00845): Plans to sell and deliver properties with a total gross floor area exceeding 70,000 square meters in 2025. Byd Company Limited (01211) reported cumulative new energy vehicle sales of approximately 700,500 units in the first three months. NIO-SW (09866) delivered 83,500 vehicles in the first quarter, a year-on-year increase of 98.3%.岚图汽车 (07489) delivered 15,019 new vehicles in March, up 50.1% year-on-year.奇瑞汽车 (09973) reported total sales across its five major brands of approximately 228,500 vehicles in March, an increase of about 15% year-on-year.长城汽车 (02333) reported total vehicle sales of approximately 106,200 units in March, an increase of 8.38% year-on-year. Geely Automobile Holdings Ltd. (00175) reported total vehicle sales of 233,000 units in March, flat compared to the same period last year.赛力斯 (09927) reported total vehicle sales of 27,500 units in March, an increase of 11.68% year-on-year. XPeng Group-W (09868) delivered 27,415 new vehicles in March. VALA (02051) delivered 564 vehicles in the first quarter, setting a new quarterly delivery record.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10